The synergy of dietary supplements Lactobacillus salivarius LI01 and Bifidobacterium longum TC01 in alleviating liver failure in rats treated with D-galactosamine.
- 2022-01-31
- Clinical Trial
- Food & Function 12(20)
- Aoxiang Zhuge
- Shengjie Li
- Yin Yuan
- Bo Li
- Lanjuan Li
- PubMed: 34546256
- DOI: 10.1039/d1fo01807h
- Low evidence
- Animal Study
Cotreatment with LI01 and TC01 more effectively decreases proinflammatory cytokines TNF-α, MCP-1 and M-CSF (p < 0.05) so as to inhibit systemic inflammation.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes